TOKU-E Talks
Find out what we're talking about
-
Posted on 08.12.21
Technically Uncertain? Solutions for Antimicrobial Susceptibility Testing challenges
Recently, I attended the virtual, global ECCMID 2021 conference and was struck with the quality and sheer volume of information presented. After attending a jam-packed workshop entitled ‘AST Testing with EUCAST Methods and Breakpoints’ m...
-
Posted on 06.04.21
Hosted a digital booth at World Microbe Forum
We hosted a digital booth at the World Microbe Forum (WMF) this year. This meeting was a collaboration between ASM, FEMS, and several other scientific societies. It took place online June 24-24, 2021. Now more than ever, we have re...
-
Posted on 04.15.21
Antimicrobial Susceptibility Testing and Beyond: Optimized antimicrobials for AST
Pharmaceutical-grade antibiotics are designed for the human body, but are not optimized for in vitro systems. There are a number of ways to optimize your AST platforms to increase efficiency and performance. Many systems require the ant...
-
Posted on 04.01.21
Antimicrobial Susceptibility Testing Series: Traditional versus Rapid AST
Unlike traditional antimicrobial susceptibility testing (AST) workflows that take days, rapid AST methods allows MICs to be determined in a matter of hours. This means the time to optimal therapy, antibiotic DOT (days on therapy), and ho...
-
Posted on 03.18.21
Antimicrobial Susceptibility Testing Series: Traditional AST methods
There is no substitute for antimicrobial susceptibility testing (AST) data when you need it. The sensitivity and resistance of pathogens to a wide range of antimicrobials is necessary so that the proper path to treatment can be dete...